BRIEF published on 06/18/2025 at 07:05, 7 months 27 days ago PHAXIAM Therapeutics suspends trading of its shares Euronext Paris Innovative Treatments PHAXIAM Suspension Of Quotation Delisting Securities
BRIEF published on 06/18/2025 at 07:05, 7 months 27 days ago PHAXIAM Therapeutics suspend la cotation de son titre Euronext Paris Suspension Cotation Traitements Innovants PHAXIAM Radiation Titres
PRESS RELEASE published on 06/18/2025 at 07:00, 7 months 27 days ago Inside Information / Other news releases PHAXIAM Therapeutics suspends trading shares for delisting on Euronext Paris market. No reimbursement to shareholders. Company focuses on innovative phage-based treatments for resistant bacterial infections Trading Delisting Suspension PHAXIAM Therapeutics Phage-based Treatments
PRESS RELEASE published on 06/18/2025 at 07:00, 7 months 27 days ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics suspend la cotation de son titre sur Euronext Paris en raison d'un prochain retrait de la cote, sans remboursement aux actionnaires Euronext Paris Cotation Suspension Retrait PHAXIAM Therapeutics
BRIEF published on 06/05/2025 at 07:05, 8 months 10 days ago PHAXIAM Therapeutics Facing Potential Liquidation Amid Court Hearing Postponement Biopharmaceuticals Judicial Liquidation Court Hearing PHAXIAM Therapeutics Euronext Delisting
BRIEF published on 06/05/2025 at 07:05, 8 months 10 days ago PHAXIAM Therapeutics menacée de liquidation suite au report de l'audience Liquidation Judiciaire Produits Biopharmaceutiques PHAXIAM Thérapeutique Audience Au Tribunal Radiation D'Euronext
PRESS RELEASE published on 06/05/2025 at 07:00, 8 months 10 days ago Inside Information / Other news releases PHAXIAM Therapeutics announces new postponement of Offer Review Hearing by Lyon Commercial Court to June 11, 2025. Company to request delisting from Euronext Euronext Delisting Postponement PHAXIAM Therapeutics Lyon Commercial Court
BRIEF published on 03/14/2025 at 17:50, 11 months 1 day ago PHAXIAM Therapeutics cherche repreneur en redressement judiciaire Euronext Paris Redressement Judiciaire PHAXIAM Therapeutics Recherche Repreneur Prolongation Procédure
BRIEF published on 03/14/2025 at 17:50, 11 months 1 day ago PHAXIAM Therapeutics seeks buyer in receivership Euronext Paris PHAXIAM Therapeutics Judicial Recovery Looking For A Buyer Extension Of Procedure
PRESS RELEASE published on 03/14/2025 at 17:45, 11 months 1 day ago Inside Information / Other news releases PHAXIAM Therapeutics launches bidding process to find buyers amid receivership, trading of shares to resume on Euronext Paris. Court decides on procedure extension on April 30, 2025 Euronext Paris Receivership PHAXIAM Therapeutics Court Decision Bidding Process
Published on 02/14/2026 at 01:00, 2 days ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 2 days 3 hours ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 2 days 7 hours ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 2 days 10 hours ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/15/2026 at 16:35, 8 hours 53 minutes ago Arab Palestinian Investment Company (APIC) achieves USD 8.13 million in net income attributable to shareholders and reports record sales of USD 1.31 billion in 2025
Published on 02/15/2026 at 11:43, 13 hours 45 minutes ago EQS-Adhoc: The Management Board of Hapag-Lloyd Aktiengesellschaft confirms negotiations regarding an acquisition of Zim Integrated Shipping Services Ltd.
Published on 02/15/2026 at 11:05, 14 hours 23 minutes ago WePlay Debuts in German Market with "The Little Prince" Special Valentine's Day Collaboration
Published on 02/15/2026 at 09:35, 15 hours 53 minutes ago Canary Islands at the Berlinale European Film Market with more than 40 professionals from the islands
Published on 02/14/2026 at 16:30, 1 day 8 hours ago Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/13/2026 at 18:05, 2 days 7 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 2 days 7 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 2 days 7 hours ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 2 days 7 hours ago Nombre total d'actions et droits de vote - janvier 2026
